These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7570345

  • 1. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system.
    Devoto P, Collu M, Muntoni AL, Pistis M, Serra G, Gessa GL, Diana M.
    Synapse; 1995 Jun; 20(2):153-5. PubMed ID: 7570345
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity.
    Liu JC, Cox RF, Greif GJ, Freedman JE, Waszczak BL.
    Eur J Pharmacol; 1994 Nov 03; 264(3):269-78. PubMed ID: 7698165
    [Abstract] [Full Text] [Related]

  • 4. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J, Trout SJ, Palij P, Whelpton R, Kruk ZL.
    Br J Pharmacol; 1995 Jun 03; 115(3):421-6. PubMed ID: 7582452
    [Abstract] [Full Text] [Related]

  • 5. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS.
    Eur J Pharmacol; 1996 Jul 25; 308(3):261-9. PubMed ID: 8858296
    [Abstract] [Full Text] [Related]

  • 6. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov 25; 275(2):899-913. PubMed ID: 7473181
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of 7-OH-DPAT, dopamine D3-receptor agonist, on nucleus accumbens neurons.
    Amano T, Matsubayashi H, Momiyama T, Sasa M.
    Jpn J Pharmacol; 1994 Jul 25; 65(3):293-5. PubMed ID: 7799531
    [Abstract] [Full Text] [Related]

  • 8. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N, Miwa Y, Adachi K, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):227-34. PubMed ID: 8858292
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C, Cummins R, Gnoffo Z, Kew JN.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):108-14. PubMed ID: 16490190
    [Abstract] [Full Text] [Related]

  • 11. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin.
    Chen NH, Reith ME.
    J Neurochem; 1995 Apr 18; 64(4):1585-97. PubMed ID: 7891086
    [Abstract] [Full Text] [Related]

  • 12. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement.
    Parsons LH, Caine SB, Sokoloff P, Schwartz JC, Koob GF, Weiss F.
    J Neurochem; 1996 Sep 18; 67(3):1078-89. PubMed ID: 8752115
    [Abstract] [Full Text] [Related]

  • 13. Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT.
    Andersen SL, Dumont NL, Teicher MH.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug 18; 356(2):173-81. PubMed ID: 9272722
    [Abstract] [Full Text] [Related]

  • 14. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K, Suzuki K, McCreary AC, Ashby CR.
    Synapse; 2006 May 18; 59(6):359-67. PubMed ID: 16463399
    [Abstract] [Full Text] [Related]

  • 15. 7-OH-DPAT injected into the accumbens reduces locomotion and sucrose ingestion: D3 autoreceptor-mediated effects?
    Gilbert DB, Cooper SJ.
    Pharmacol Biochem Behav; 1995 Oct 18; 52(2):275-80. PubMed ID: 8577791
    [Abstract] [Full Text] [Related]

  • 16. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
    Rivet JM, Audinot V, Gobert A, Peglion JL, Millan MJ.
    Eur J Pharmacol; 1994 Nov 24; 265(3):175-7. PubMed ID: 7875234
    [Abstract] [Full Text] [Related]

  • 17. Gradient of dopamine responsiveness to dopamine receptor agonists in subregions of the rat nucleus accumbens.
    Shilliam CS, Heidbreder CA.
    Eur J Pharmacol; 2003 Sep 12; 477(2):113-22. PubMed ID: 14519414
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
    Levant B, Garimelli B, Shafer RA, Merchant KM.
    Neuropsychopharmacology; 1999 Aug 12; 21(2):304-11. PubMed ID: 10432478
    [Abstract] [Full Text] [Related]

  • 19. Dopamine and 7-OH-DPAT may act on D(3) receptors to inhibit tuberoinfundibular dopaminergic neurons.
    Lin JY, Yen SH, Shieh KR, Liang SL, Pan JT.
    Brain Res Bull; 2000 Aug 12; 52(6):567-72. PubMed ID: 10974498
    [Abstract] [Full Text] [Related]

  • 20. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J, Meltzer HY.
    J Pharmacol Exp Ther; 1999 Dec 12; 291(3):1227-32. PubMed ID: 10565846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.